EN
0
Home > Products > Pharmaceuticals & Life Science > Pharmaceutical Intermediates > (R)-4-((3R,5S,6S,7S,10S,13R)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid
(R)-4-((3R,5S,6S,7S,10S,13R)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid structure, CAS 1708092-13-0

(R)-4-((3R,5S,6S,7S,10S,13R)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

CAS Number1708092-13-0

SynonymsInChIKey ZXERDUOLZKYMJM-QJBYOJSOSA-N; Synonyms

Molecular FormulaC26H44O4

Molecular Weight420.6

Purity

Density

Boiling Point

Melting Point

Flash Point

Appearance

EINECS

MSDSChineseEnglish

Symbol

Signal Word

Cat. No.: 2A-3179669 Purity:
Change View

Please Login or Create an Account to: See VlP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

Inquiry

Quality Control of [ 1708092-13-0 ] SDS Specification MoL

COA NMR CNMR HPLC LC-MS
Chemical & Physical Properties
CAS Number1708092-13-0
Catalog No.2A-3179669
Chinese Name奥贝胆酸杂质 20
SynonymsInChIKey ZXERDUOLZKYMJM-QJBYOJSOSA-N; Synonyms
Molecular FormulaC26H44O4
Molecular Weight420.6
PubChem ID332832878
SMILESCCC1C(O)C2C3CCC(C(C)CCC(=O)O)C3(C)CCC2C2(C)CCC(O)CC12
InChIInChI=1S/C26H44O4/c1-5-17-21-14-16(27)10-12-26(21,4)20-11-13-25(3)18(15(2)6-9-22(28)29)7-8-19(25)23(20)24(17)30/h15-21,23-24,27,30H,5-14H2,1-4H3,(H,28,29)/t15-,16-,17+,18-,19+,20+,21+,23+,24+,25-,26-/m1/s1
InChI KeyZXERDUOLZKYMJM-QJBYOJSOSA-N
Transport InfoProduct name: Obeticholic acid impurity 2
Related Products in Pharmaceutical Intermediates
(3aR,4S,7R,7aS)-2-(((1S,2S)-2-((4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)methyl)cyclohexyl)methyl)hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione1448443-35-32A-3179623
(3aR,4S,7R,7aS)-2-{(1S,2S)-2-[4-(1,2-benzisothiazol-3-yl)piperazin-1-ylMethyl]cyclohexylMethyl}hexahydro-4,7-Methano-2H-isoindole-1,3-dione hydrochloride139563-18-12A-3179624
((1R,2R)-2-(((3aR,4S,7R,7aS)-1,3-dioxooctahydro-2H-4,7- methanoisoindol-2-yl)methyl)cyclohexyl)methyl 4-(benzo[d] isothiazol-3-yl)piperazine-1-carboxylate1807983-62-52A-3179630
((1R,2R)-cyclohexane-1,2-diyl)bis(methylene) bis(4-(benzo[d] isothiazol-3-yl)piperazine-1-carboxylate)1807983-61-42A-3179631
(3aR,4R,7S,7aS)-rel-2-[[(1R,2R)-2-[[4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl]methyl]cyclohexyl]methyl]hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione hydrochloride (1:1)139563-24-92A-3179633
(R)-4-((3R,5S,6S,7R,10S,13R)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid915038-27-62A-3179672
(3R,5S,6R,7R,10S,13R)-6-ethyl-17-((R)-5-hydroxypentan-2-yl)-10,13-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol1537866-49-12A-3179673
(4R)-4-((3R,5R,10R,13R)-6-ethylidene-3-hydroxy-10,13-dimethyl-7-oxohexadeca hydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid915038-24-32A-3179676
(4R)-4-[(3S,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid566-24-52A-3179679
(5Z)-N-(Cyclopropylmethyl)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxy-4-phenoxy-1-buten-1-yl]cyclopentyl]-5-heptenamide1138395-09-12A-2179690
Browse all Pharmaceutical Intermediates products »
Contact Us

Phone:

630-322-8886

630-322-8887

Email:

[email protected]

Office Locations:

Chicago, IL, USA

San Francisco, CA, USA